| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gsk PLC | 10% Owner | 2025-12-11 | 1,470,000 | $19.00 | $27.93MBuy |
| Kyle Moran | Chief Financial Officer | 2025-12-09 | 50,000 | $20.03 | $1.00MSell |
| Kyle Moran | Chief Financial Officer | 2025-12-09 | 50,000 | $10.48 | $524.00kBuy |
| Kyle Moran | Chief Financial Officer | 2025-12-09 | 36 | $20.25 | $729.00Sell |
| Kyle Moran | Chief Financial Officer | 2025-12-09 | 36,000 | $8.17 | $294.12kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2025-12-08 | 107,400 | $3.87 | $415.64kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2025-12-08 | 107,400 | $14.56 | $1.56MSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2025-12-08 | 45,882 | $4.75 | $217.94kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2025-12-08 | 45,882 | $14.50 | $665.29kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2025-12-08 | 9,375 | $3.14 | $29.44kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gsk PLC | 17.30% | 28,929,452 | $461.42M | Insider |
| Ra Capital Management LP | 10.89% | 18,202,009 | $290.32M | Institution |
| Adage Capital Partners GP LLC | 8.71% | 14,567,784 | $232.36M | Institution |
| Blackrock Inc | 6.24% | 10,430,813 | $166.37M | Institution |
| Maverick Capital Ltd | 5.02% | 8,391,856 | $133.85M | Institution |
| Ken Takanashi | 4.61% | 7,713,133 | $123.02M | Insider |
| Ra Capital Management LP | 4.55% | 7,602,428 | $121.26M | Insider |
| Driehaus Capital Management LLC | 3.77% | 6,298,060 | $100.45M | Institution |
| M28 Capital Management LP | 3.39% | 5,664,548 | $90.35M | Institution |
| Fmr LLC | 3.07% | 5,130,374 | $81.83M | Institution |